Shares of Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB – Get Free Report) traded up 1.1% during mid-day trading on Thursday . The company traded as high as $0.80 and last traded at $0.78. 57,993 shares traded hands during mid-day trading, a decline of 49% from the average session volume of 112,780 shares. The stock had previously closed at $0.77.
Lakeshore Biopharma Price Performance
The company has a 50-day simple moving average of $0.52. The company has a quick ratio of 0.87, a current ratio of 1.13 and a debt-to-equity ratio of 0.17.
About Lakeshore Biopharma
LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.
See Also
- Five stocks we like better than Lakeshore Biopharma
- What Are Dividend Champions? How to Invest in the Champions
- CarMax’s Impressive Rally: What Investors Should Watch Next
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- MarketBeat Week in Review – 9/23 – 9/27
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
